NCT06810336View on ClinicalTrials.gov

Pain Control and Quality of Recovery After Intravenous Methadone Versus Intravenous Remifentanil in Craniotomy Surgery

EARLY_PHASE1Not yet recruitingINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

March 10, 2025

Primary Completion Date

September 10, 2026

Study Completion Date

September 10, 2026

Conditions
Brain InjuryBrain TumorsCraniotomy SurgeryPainPostoperativePostoperative Care
Interventions
DRUG

Remifentanil

Intravenous Remifentanil

DRUG

Methadone

Intravenous Methadone

Trial Locations (1)

22908-0710

University of Virginia, Charlottesville

All Listed Sponsors
lead

University of Virginia

OTHER